Summer Workshop: Fragment-based Compound Evolution

webinar

Wed, 21 Jul 2021, 16:00 CEST (Berlin)

Alexander Neumann, BioSolveIT

Summer Workshop: Fragment-based Compound Evolution

Fragment-based drug design (FBDD) receives more and more attention in the scientific community. The the fifth fragment-derived drug, sotorasib, received approval by the FDA for the treatment of non-small cell lung cancer this year. In this workshop we will discuss strategies around FBDD with recent med-chem use cases and how to utilize resources for lead optimization and idea generation. by thinking outside the box. Learn how to evolve a weak binder to a full-fledged drug candidate.

Participants can request a certificate of attendance.

Current news

25 Years of BioSolveIT: Thank You!
November 20, 2026 06:37 CET
Your targets. Your compounds. Your questions. For our 25th anniversary, we opened up free access to SeeSAR and Chemical Space DockingĀ® through November 15. The idea was simple: give you time to see what the tools could do with a target or compound you already knew well. Maybe you revisited...
Read on
CHEMriya Update November
November 11, 2026 11:19 CET
More Chemistry. More Possibilities. The latest update of CHEMriya brings over 794 billion virtual product molecules to your compound exploration. Developed by OTAVA in collaboration with BioSolveIT, this on-demand Chemical Space opens up new opportunities for hit expansion, hit-to-lead optimization, and compound evolution. The November 2026 release combines OTAVA’s chemistry...
Read on
category
Challenge
Winter 2026 Scientific Challenge Deadline Approaching
November 3, 2026 13:18 CET
The Winter 2026 Scientific Challenge is here! We invite researchers from academia (students, postdocs, and professors), non-profit organizations, and independent researchers to take part. Whether you are exploring a new drug discovery idea or looking to advance an existing project, our software can help you take your research further. How...
Read on